Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.72 USD | +0.07% |
|
+2.70% | +5.24% |
| 16/06 | Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says | MT |
| 11/06 | Edwards Lifesciences Set to Benefit from TAVR Coverage Update, RBC Says | MT |
| Market Cap | 5.17TCr 4.54TCr 4.18TCr 3.91TCr 7.33TCr 4,87500Cr 7.47TCr 50TCr 19TCr 2,40300Cr 19TCr 19TCr 8,35100Cr | P/E 2026 * |
32x | P/E 2027 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.82TCr 4.23TCr 3.9TCr 3.65TCr 6.84TCr 4,54600Cr 6.96TCr 47TCr 18TCr 2,24100Cr 18TCr 18TCr 7,78800Cr | EV / Sales 2026 * |
7.14x | EV / Sales 2027 * | 6.29x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.07% | ||
| 1 week | +2.70% | ||
| Current month | +3.76% | ||
| 1 month | +4.59% | ||
| 3 months | +8.53% | ||
| 6 months | +3.97% | ||
| Current year | +5.24% |
| 1 week | 85.32 |  | 91.65 |
| 1 month | 83.17 | | 91.65 |
| Current year | 74.66 | | 91.65 |
| 1 year | 72.3 | | 91.65 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/06 | Sell | Chief Executive Officer | -523 | 0.0001% | ||
| 29/05 | Sell | Controller/Auditor | -568 | 0.0001% | ||
| 27/05 | Sell | Executive/Senior Manager | -23,145 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.07% | +2.70% | +16.56% | -0.69% | 5.17TCr | |
| +2.75% | +8.85% | +23.16% | -3.52% | 19TCr | |
| -0.53% | -1.74% | -23.38% | +22.13% | 14TCr | |
| +2.30% | +9.05% | -3.88% | -18.88% | 14TCr | |
| -0.58% | -2.41% | -57.62% | -18.10% | 6.57TCr | |
| -0.57% | 0.00% | -26.92% | -32.27% | 4.37TCr | |
| +2.95% | +6.65% | +14.24% | +13.47% | 3.83TCr | |
| +2.09% | +6.03% | +7.68% | +45.05% | 3.7TCr | |
| +0.09% | +5.44% | -10.74% | -18.64% | 2.95TCr | |
| +1.07% | +5.29% | -23.00% | -7.74% | 2.87TCr | |
| Average | +1.21% | +3.21% | -8.39% | -1.92% | 7.61TCr | |
| Weighted average by Cap. | +1.53% | +3.32% | -4.92% | -1.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 674.8Cr 592.75Cr 546.12Cr 510.64Cr 957.71Cr 64TCr 975.29Cr 6.55TCr 2.54TCr 31TCr 2.53TCr 2.48TCr 1,09100Cr | 741.05Cr 650.94Cr 599.74Cr 560.77Cr 1.05TCr 70TCr 1.07TCr 7.2TCr 2.79TCr 34TCr 2.78TCr 2.72TCr 1,19800Cr |
| Net income | 162.43Cr 142.68Cr 131.46Cr 122.91Cr 230.53Cr 15TCr 234.76Cr 1.58TCr 610.91Cr 7.56TCr 609.97Cr 596.6Cr 26TCr | 189.11Cr 166.12Cr 153.05Cr 143.11Cr 268.4Cr 18TCr 273.32Cr 1.84TCr 711.27Cr 8.8TCr 710.17Cr 694.61Cr 31TCr |
| Net Debt | -348.23Cr -305.89Cr -281.83Cr -263.51Cr -494.23Cr -33TCr -503.3Cr -3.38TCr -1.31TCr -16TCr -1.31TCr -1.28TCr -56TCr | -507.26Cr -445.58Cr -410.53Cr -383.85Cr -719.93Cr -48TCr -733.14Cr -4.93TCr -1.91TCr -24TCr -1.9TCr -1.86TCr -82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | $89.72 | +0.07% | 43,18,766 |
| 24/26/24 | $89.66 | +3.12% | 45,11,691 |
| 23/26/23 | $86.95 | +1.25% | 42,28,237 |
| 22/26/22 | $85.88 | -1.69% | 35,06,790 |
| 18/26/18 | $87.36 | +0.78% | 55,50,251 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
